Search results for "Compounding"

showing 10 items of 112 documents

Environmental and Product Contamination during the Preparation of Antineoplastic Drugs with Robotic Systems

2018

Abstract Background Robotic systems are designed to minimize the exposure to antineoplastic drugs during automated preparation. However, contamination cannot be completely excluded. The aim of the study was to evaluate the contamination with antineoplastic drugs on the working surfaces and on the outer surface of the ready-to-use products (infusion bags and syringes) during automated preparation with different versions of a robot and manual preparation. Methods Surface contamination with platinum (Pt) and 5-fluorouracil (5-FU) was measured by wipe sampling and quantified by voltammetry for Pt and GC-MS for 5-FU. Sampling was performed on pre-defined locations in the working areas before and…

PharmacyRM1-950030226 pharmacology & pharmacygas chromatography/mass spectrometryantineoplastic drugs03 medical and health sciences0302 clinical medicineMedicinePharmacology (medical)Pharmaceutical industryPharmacologyvoltammetryChromatographybusiness.industrysurface contaminationautomated compoundingContaminationwipe samplingRobotic systems030220 oncology & carcinogenesisProduct (mathematics)Antineoplastic DrugsTherapeutics. PharmacologyGas chromatography–mass spectrometryHD9665-9675businessWipe samplingPharmaceutical Technology in Hospital Pharmacy
researchProduct

Formulation predictive dissolution (fPD) testing to advance oral drug product development: an introduction to the US FDA funded ‘21st Century BA/BE’ …

2018

Over the past decade, formulation predictive dissolution (fPD) testing has gained increasing attention. Another mindset is pushed forward where scientists in our field are more confident to explore the in vivo behavior of an oral drug product by performing predictive in vitro dissolution studies. Similarly, there is an increasing interest in the application of modern computational fluid dynamics (CFD) frameworks and high-performance computing platforms to study the local processes underlying absorption within the gastrointestinal (GI) tract. In that way, CFD and computing platforms both can inform future PBPK-based in silico frameworks and determine the GI-motility-driven hydrodynamic impac…

Physiologically based pharmacokinetic modellingBioavailabilityComputer scienceManometryDrug CompoundingAdministration OralPharmaceutical Science02 engineering and technologyBioequivalenceComputational fluid dynamics030226 pharmacology & pharmacyArticleDOSAGE FORMSINDUCED VARIABILITY03 medical and health sciences0302 clinical medicineBIOPHARMACEUTICS CLASSIFICATION-SYSTEMABSORPTIONHumansDissolution testingOral absorptionPharmacology & PharmacyDissolutionIN-VIVO DISSOLUTIONIn vivo dissolutionBioequivalenceScience & TechnologyWORKSHOP REPORTUnited States Food and Drug Administrationbusiness.industryGASTROINTESTINAL SIMULATOR GISVITRO DISSOLUTION021001 nanoscience & nanotechnologyBiopharmaceutics Classification SystemUnited StatesMODELDrug LiberationNew product developmentPredictive powerDIFFUSION-CONTROLLED DISSOLUTIONBiochemical engineering0210 nano-technologybusinessLife Sciences & BiomedicineOral retinoidMRI
researchProduct

IMI – Oral biopharmaceutics tools project – Evaluation of bottom-up PBPK prediction success part 2: An introduction to the simulation exercise and ov…

2016

Orally administered drugs are subject to a number of barriers impacting bioavailability (Foral), causing challenges during drug and formulation development. Physiologically-based pharmacokinetic (PBPK) modelling can help during drug and formulation development by providing quantitative predictions through a systems approach. The performance of three available PBPK software packages (GI-Sim, Simcyp®, and GastroPlus™) were evaluated by comparing simulated and observed pharmacokinetic (PK) parameters.Since the availability of input parameters was heterogeneous and highly variable, caution is required when interpreting the results of this exercise. Additionally, this prospective simulation exer…

Physiologically based pharmacokinetic modellingChemistryBiopharmaceuticsDrug Evaluation PreclinicalArea under the curveAdministration OralPharmaceutical ScienceModels Biological030226 pharmacology & pharmacyBiopharmaceuticsBioavailabilityClinical studyToxicology03 medical and health sciences0302 clinical medicineIntestinal AbsorptionPharmaceutical PreparationsPharmacokineticsCompounding030220 oncology & carcinogenesisStatisticsHumansComputer SimulationImmediate releaseForecastingEuropean Journal of Pharmaceutical Sciences
researchProduct

Synthesis of Novel Folic Acid-Functionalized Biocompatible Block Copolymers by Atom Transfer Radical Polymerization for Gene Delivery and Encapsulati…

2005

Two synthetic routes to folic acid (FA)-functionalized diblock copolymers based on 2-(methacryloyloxy)- ethyl phosphorylcholine [MPC] and either 2-(dimethylamino)ethyl methacrylate [DMA] or 2-(diisopropylamino) ethyl methacrylate [DPA] were explored. The most successful route involved atom transfer radical polymerization (ATRP) of MPC followed by the tertiary amine methacrylate using a 9-fluorenylmethyl chloroformate (Fmoc)-protected ATRP initiator. Deprotection of the Fmoc groups produced terminal primary amine groups, which were conjugated with FA to produce two series of novel FA-functionalized biocompatible block copolymers. Nonfunctionalized MPC-DMA diblock copolymers have been previou…

Polymers and PlasticsTertiary aminePolymersDrug CompoundingBiocompatible MaterialsBioengineeringChloroformateConjugated systemMethacrylateBiomaterialschemistry.chemical_compoundFolic AcidPolymer chemistryMaterials ChemistryCopolymerPOLYMER SYNTHESIS ATRPDrug CarriersMolecular StructureAtom-transfer radical-polymerizationGenetic TherapyHydrogen-Ion ConcentrationEnd-groupchemistrySettore CHIM/09 - Farmaceutico Tecnologico ApplicativoDrug carrierHydrophobic and Hydrophilic InteractionsBiomacromolecules
researchProduct

Sumatriptan Succinate Transdermal Delivery Systems for The Treatment of Migraine

2007

We have successfully obtained sumatriptan transdermal systems with different polymer compositions: methyl cellulose (MC), polyvinyl pyrrolidone (PVP) and a polyvinyl pyrrolidone (PVP)-polyvinyl alcohol (PVA) mixture. The systems contained 1,2-propylenglycol (MC) or sorbitol as a plasticizer (PVP and PVP-PVA), methacrylate copolymer as an adhesive agent, and an occlusive liner. Azone (5%, w/w) was incorporated into all the systems as a percutaneous enhancer. Transdermal systems are thin, transparent and non-adhesive when in a dry state. The permeation of sumatriptan succinate across pig ear skin was studied using the systems prepared. The formulation with MC polymer produced a statistically …

PolymersSwineChemistry PharmaceuticalDrug CompoundingMigraine DisordersSkin AbsorptionPharmaceutical Sciencemacromolecular substancesAbsorption (skin)MethylcellulosePharmacologyAdministration CutaneousPermeabilityDosage formchemistry.chemical_compoundPolymethacrylic AcidsPlasticizersSumatriptan SuccinatemedicineAnimalsSorbitolTechnology PharmaceuticalVasoconstrictor AgentsSkinTransdermalDrug Carriersintegumentary systemSumatriptanChemistrytechnology industry and agriculturePlasticizerPovidoneAzepinesIontophoresisPermeationPropylene GlycolSerotonin Receptor AgonistsKineticsSumatriptanPolyvinyl AlcoholMethyl celluloseDiffusion Chambers CultureTissue AdhesivesNuclear chemistrymedicine.drugJournal of Pharmaceutical Sciences
researchProduct

Quantitative and qualitative control of antineoplastic preparations: Gravimetry versus HPLC.

2019

This article compares gravimetry vs. high-performance liquid chromatography (HPLC) as quality control (QC) methods for paclitaxel, docetaxel and oxaliplatin preparations. We aimed at assessing the preparation method reliability in our hospital, evaluating compounding accuracy and estimating the influence of personnel training and standardized homogenization on compounding accuracy. Agreement, correlation, concordance, accuracy and precision between methods were evaluated for each drug. Conforming preparation percentages (CPs) at different tolerance limits (TLs) and compounding accuracy were calculated for each method and drug. Compounding accuracy was compared before and after personnel tra…

Quality ControlAccuracy and precisionPaclitaxelCytostatic agentsAntineoplastic AgentsDocetaxelHigh-performance liquid chromatographyPreparation method03 medical and health sciences0302 clinical medicineMedicineHumansPharmacology (medical)GravimetryChromatography High Pressure LiquidDrug compoundingChromatographybusiness.industryReproducibility of ResultsOncologyDocetaxelCompounding030220 oncology & carcinogenesisbusiness030215 immunologymedicine.drugJournal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
researchProduct

Development of extracellular vesicle-based medicinal products: A position paper of the group “Extracellular Vesicle translatiOn to clinicaL perspecti…

2021

International audience; Extracellular vesicles (EV) are emergent therapeutic effectors that have reached clinical trial investigation. To translate EV-based therapeutic to clinic, the challenge is to demonstrate quality, safety, and efficacy, as required for any medicinal product. EV research translation into medicinal products is an exciting and challenging perspective. Recent papers, provide important guidance on regulatory aspects of pharmaceutical development, defining EVs for therapeutic applications and critical considerations for the development of potency tests. In addition, the ISEV Task Force on Regulatory Affairs and Clinical Use of EV-based Therapeutics as well as the Exosomes C…

Quality ControlKnowledge management[SDV.BIO]Life Sciences [q-bio]/BiotechnologyBiological medicinal productsmedia_common.quotation_subjectDrug Compounding[SDV]Life Sciences [q-bio]Regulatory requirementsPharmaceutical ScienceMarketing authorizationExosomesChemistry Techniques Analytical03 medical and health sciencesExtracellular Vesicles0302 clinical medicineDrug DevelopmentDrug Stability[CHIM]Chemical SciencesHumansQuality (business)ComputingMilieux_MISCELLANEOUS030304 developmental biologymedia_commonCell-free therapySecretome0303 health sciencesClinical Trials as TopicClinical-grade EVScientific progressbusiness.industryDrug Administration RoutesExtracellular vesicleDrugs InvestigationalRegulatory affairs3. Good health[SDV.BIO] Life Sciences [q-bio]/BiotechnologyClinical trialEuropeAnalytics030220 oncology & carcinogenesisPosition paperMedicinal productsBusinessMicrovesicles
researchProduct

Improvement of the wettability and dissolution of fenofibrate compacts by plasma treatment

2011

Abstract The goal of this study was to investigate the effect of plasma treatment on the wettability and dissolution of fenofibrate compacts. Contact angle measurements and intrinsic dissolution rate studies of untreated and plasma-treated fenofibrate compacts were conducted. The contact angle data clearly show that the wettability of the tablet surface increased with the duration of plasma treatment. Analyses of stability revealed that the surfaces which were plasma-treated for more than 1 min regained some degree of hydrophobicity after storage in air. Since their hydrophobic recovery finally reached the level observed with 1 min plasma-treated fenofibrate compacts it was deduced that per…

Radiation NonionizingMaterials sciencePlasma irradiationFenofibrateChromatographyDrug CompoundingPharmaceutical SciencePlasma treatmentOxygenContact angleFenofibrateSolubilityChemical engineeringWettabilitymedicineWettingSolubilitySaturation (chemistry)Hydrophobic and Hydrophilic InteractionsDissolutionTabletsmedicine.drugInternational Journal of Pharmaceutics
researchProduct

Low density lipoproteins and human serum albumin as the carriers of squalenoylated drugs: insights from molecular simulations

2018

We have studied the interaction of three clinically promising squalenoylated drugs (gemcitabine-squalene, adenine-squalene, and doxorubicin-squalene) with low-density lipoproteins (LDL) by means of atomistic molecular dynamics simulations. It is shown that all studied squalenoylated drugs accumulate inside the LDL particles. This effect is promoted by the squalene moiety, which acts as an anchor and drives the hydrophilic drugs into the hydrophobic core of the LDL lipid droplet. Our data suggest that LDL particles could be a universal carriers of squalenoylated drugs in the bloodstream. Interaction of gemcitabine-squalene with human serum albumin (HSA) was also studied by ensemble of dockin…

Squalene[PHYS.PHYS.PHYS-BIO-PH]Physics [physics]/Physics [physics]/Biological Physics [physics.bio-ph]Drug CompoundingPharmaceutical ScienceSerum Albumin Human02 engineering and technologyPlasma protein bindingMolecular Dynamics Simulation010402 general chemistry01 natural sciencesMolecular Docking SimulationDeoxycytidineSqualenechemistry.chemical_compound[ PHYS.PHYS.PHYS-BIO-PH ] Physics [physics]/Physics [physics]/Biological Physics [physics.bio-ph]Lipid dropletDrug DiscoverymedicineMoietyHumansComputingMilieux_MISCELLANEOUSDrug CarriersBinding SitesAdenine[SDV.SP]Life Sciences [q-bio]/Pharmaceutical sciences021001 nanoscience & nanotechnologyHuman serum albuminGemcitabine3. Good health0104 chemical sciences[CHIM.THEO]Chemical Sciences/Theoretical and/or physical chemistryLipoproteins LDLMolecular Docking Simulation[ SDV.SP ] Life Sciences [q-bio]/Pharmaceutical scienceschemistryDocking (molecular)Doxorubicin[ CHIM.THEO ] Chemical Sciences/Theoretical and/or physical chemistryBiophysicsMolecular MedicineNanoparticles0210 nano-technologyDrug carrierHydrophobic and Hydrophilic Interactionsmedicine.drugProtein Binding
researchProduct

Microparticles derived from marine sponge collagen (SCMPs): preparation, characterization and suitability for dermal delivery of all-trans retinol.

2002

Abstract Collagen microparticles were prepared using marine sponge collagen. For this purpose a previous method by Rossler et al. (J. Microencapsul. 12 (1995) 49) of emulsification and cross-linking of native calf collagen was modified. The modified method for sponge collagen microparticles (SCMPs) achieved a yield of 10%. Scanning electromicroscopic photographs showed spherical particles with a diameter of 120–300 nm and photon correlation spectroscopic measurements indicated particle size range from 126 (±2.9) to 2179 (±342) nm. This broad size distribution was caused by some agglomerates that could not be destroyed by ultrasonication. The surface charge was measured as a function of pH. …

StereochemistrySonicationDrug CompoundingSkin AbsorptionPharmaceutical ScienceIn Vitro TechniquesAdministration CutaneousDosage formMiceDrug StabilityAnimalsAll trans retinolMicroparticleParticle SizeVitamin ADrug CarriersMice HairlessChromatographyChemistryGeneral MedicinePenetration (firestop)PoriferaSelf-healing hydrogelsFemaleParticle sizeCollagenDrug carrierBiotechnologyEuropean journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
researchProduct